Common COVID-19 antibiotic flops in clinical trial: Experts weigh in

common covid 19 antibiotic flops in clinical trial experts weigh in

Sumary of Common COVID-19 antibiotic flops in clinical trial: Experts weigh in:

  • Findings from researchers affiliated with University of California San Francisco published in JAMA Network on July 16 analyzed 263 COVID-19 outpatients, 171 of whom were treated with a single 1.2-g oral dose of the antibiotic, while 92 patients were given a placebo.
  • Glatt, the chairman of the department of medicine and chief of infectious diseases at Mount Sinai South Nassau, added: “There is no evidence that it provides any benefit to treat Covid and it should not be used unless there is an appropriate bacterial indication.
  • “CDC SAYS ‘NO PLANS TO UPDATE’ SCHOOL MASK GUIDANCE AFTER PEDIATRICS GROUP BREAKS FROM WHITE HOUSEAntibiotics like azithromycin are often used to treat bacterial infections like pneumonia and sexually transmitted infections, according to Dr. Anthony J.
  • “These findings do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection,” Oldenburg wrote.

Want to know more click here go to source.

From -

Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.